S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RVPHW Reviva Pharmaceuticals Holdings Inc

0.15

0.00 (0.00%)

Pre Market

Last Updated: 23:00:04

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Reviva Pharmaceuticals (NASDAQ:RVPHW)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Reviva Pharmaceuticals Charts.

Reviva Pharmaceuticals (NASDAQ:RVPHW)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Reviva Pharmaceuticals Charts.

Reviva Pharmaceuticals Holdings Inc News

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 21 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 29 October 2024 (4 months ago) • Edgar (US Regulatory)

More Reviva Pharmaceuticals Holdings Inc News Articles

Commonwealth Bank Of Aus...

S&P ASX 300 Metals and M...

Sterling vs AUD

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions